Vaccines and Viral Vectors

Robust, rapid testing for critical quality attributes (CQA) is essential for vaccine assay and viral vector development. For the expert analytical and bioanalytical services to move your products efficiently to preclinical and clinical trials, go with Prolytix.

With immense experience in host cell protein analysis, Prolytix has the expertise to solve your vaccine and viral vector development challenges.

Contact one of our experts to find out how we can advance your vaccine and viral vector development.